Onera Health has successfully raised €30 million in a funding round led by EQT Life Sciences and Gimv to enhance its sleep diagnostics solutions and expedite product implementation.
Target Information
Onera Health, founded in 2017 and based in Eindhoven, specializes in developing innovative sleep diagnostics and monitoring solutions aimed at assisting individuals with sleep-related disorders. The company is committed to enhancing patient care and outcomes through advanced technology in sleep medicine.
By leveraging cutting-edge research and development, Onera Health aims to address the growing need for effective sleep health management, offering products that provide accurate monitoring and diagnostics for various sleep conditions.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The sleep diagnostics industry has gained significant traction in recent years, particularly in Europe and the United States, where increasing awareness of sleep-related disorders has prompted a s
Similar Deals
Frazier Life Sciences, Droia Ventures → Alesta Therapeutics
2025
Brightlands Venture Partners → Novenda Technologies
2023
EQT Life Sciences, Gimv
invested in
Onera Health
in 2023
in a Series A deal
Disclosed details
Transaction Size: $32M